Back to Search Start Over

Visceral metastases should distinguish between liver or lung when treating HR-positive/HER2-negative advanced breast cancer with fulvestrant

Authors :
Zhe Wang
Junjie Li
Zhimin Shao
W.-J. Zuo
M. He
Source :
The Breast. 44:S59
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Subjects

Subjects :
Oncology
medicine.medical_specialty
Lung
Fulvestrant
business.industry
Advanced breast
HER2 negative
Cancer
General Medicine
medicine.disease
medicine.anatomical_structure
Internal medicine
medicine
Surgery
business
medicine.drug

Details

ISSN :
09609776
Volume :
44
Database :
OpenAIRE
Journal :
The Breast
Accession number :
edsair.doi...........5b8c87ca32adaa5997d780930a0e4fc2
Full Text :
https://doi.org/10.1016/s0960-9776(19)30230-9
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details